Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness

Eur Respir J. 2017 May 25;49(5):1601858. doi: 10.1183/13993003.01858-2016. Print 2017 May.

Authors

John Politis¹, Brian Le², Natasha Smallwood³

Affiliations

¹ Dept of Respiratory Medicine, The Royal Melbourne Hospital, Parkville, Australia.
² Palliative and Supportive Care, The Royal Melbourne Hospital, Parkville, Australia.
³ Dept of Respiratory Medicine, The Royal Melbourne Hospital, Parkville, Australia Natasha.smallwood@mh.org.au.

PMID: 28546278
DOI: 10.1183/13993003.01858-2016

No abstract available

Publication types

Letter
Comment

MeSH terms

Dyspnea*
Humans
Morphine*
Pulmonary Disease, Chronic Obstructive
Respiratory Insufficiency

Substances

Morphine